C533 (Tenofovir Disoproxil Fumarate 300 mg)
Pill with imprint C533 is Blue, Capsule-shape and has been identified as Tenofovir Disoproxil Fumarate 300 mg. It is supplied by Cipla USA Inc..
Tenofovir is used in the treatment of hepatitis b; occupational exposure; hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Tenofovir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C533
Tenofovir Disoproxil Fumarate
- Imprint
- C533
- Strength
- 300 mg
- Color
- Blue
- Size
- 17.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (nrtis)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- National Drug Code (NDC)
- 69097-0533
- Inactive Ingredients
-
lactose monohydrate,
croscarmellose sodium,
corn starch,
polysorbate 80,
microcrystalline cellulose,
magnesium stearate,
titanium dioxide,
triacetin,
FD&C Blue No. 2,
hypromellose 2910 (15 mPa.s)
Note: Inactive ingredients may vary.
More about tenofovir
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- 22 Reviews
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Consumer resources
- Patient Information
- Tenofovir (Advanced Reading)
- Tenofovir Disoproxil Fumarate Tablets
- Tenofovir Disoproxil Fumarate Oral Powder
- Other brands
- Viread
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.